POTENTIA PHARMACEUTICALS
Potentia Pharmaceuticals is a biotechnology company, develops anti-inflammatory drugs/therapeutics.
POTENTIA PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
2001-01-01
Address:
Crestwood, Kentucky, United States
Country:
United States
Total Employee:
1+
Status:
Active
Similar Organizations
1st Human Therapeutics
1st Human Therapeutics is a biotechnology company focused on developing first-in-human therapeutics.
Anteros Pharmaceuticals
Anteros Pharmaceuticals is a biotechnology company that develops drugs for fibrotic and other inflammatory diseases.
Upaya Pharmaceuticals
Upaya Pharmaceuticals is a biotechnology company that develops solutions to address multi-drug resistant infections.
Investors List
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Seed Round - Potentia Pharmaceuticals
More informations about "Potentia Pharmaceuticals"
Potentia Pharmaceuticals, Inc. Overview - SignalHire
Potentia Pharmaceuticals, Inc. is a private company that has been in the industry for 20 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: …See details»
Potentia Pharmaceuticals - PitchBook
Potentia Pharmaceuticals General Information Description. Developer of therapeutics and drug delivery technologies. The company develops novel therapeutics and drug delivery technologies to address chronic inflammatory …See details»
Potentia Pharmaceuticals Inc - Company Profile and News
Potentia Pharmaceuticals, Inc. operates as a biotechnology company. The Company focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory …See details»
Potentia Pharmaceuticals - Products, Competitors, Financials, …
Potentia Pharmaceuticals is an early stage biotechnology company focused on developing therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an …See details»
Potentia Pharmaceuticals - Ownership and Business Overview
Nov 20, 2014 Potentia Pharmaceuticals is a biotechnology company, that focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, …See details»
Potentia Pharmaceuticals - Funding, Financials, Valuation & Investors
Oct 5, 2006 Organization. Potentia Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding …See details»
Potentia Pharmaceuticals, Inc. Enters into Licensing and Purchase ...
Oct 23, 2009 Potentia Pharmaceuticals, Inc. Enters into Licensing and Purchase Option Agreements with Alcon Laboratories, Inc. (ACL); Deal Provides Path for Alcon to Acquire …See details»
Potentia Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Potentia Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 3 literature, Drug:APL-1.See details»
Potentia Pharmaceuticals - Crunchbase
Potentia Pharmaceuticals is a biotechnology company, develops anti-inflammatory drugs/therapeutics.See details»
Potentia Pharmaceuticals - VentureRadar
Skinvisible Pharmaceuticals USA n/a Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer …See details»
Potentia Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Dec 15, 2014 Potentia Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Potentia Pharmaceuticals, Inc. - Louisville, USA
Potentia Pharmaceuticals, Inc. is a biotechnology company focused on developing novel therapeutics to address ophthalmological diseases. HealthCare Ventures and MASA Life …See details»
Potentia Pharmaceuticals Inc | www.inknowvation.com
Potentia Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing innovative therapeutics primarily in the area of age-related macular degeneration and other …See details»
Potentia Pharmaceuticals Inc. - Scrip
Jun 1, 2005 Formerly started as an early stage nanotechnology company, Potentia Pharmaceuticals Inc. is now focused on developing novel therapeutics for macular …See details»
Apellis to Acquire Potentia, Four Years After Spinout
Nov 20, 2014 Apellis was founded in 2010 as a spin-off of Potentia Pharmaceuticals, to continue the development of therapies in non-ocular diseases such as severe asthma and COPD. …See details»
Potentia Pharmaceuticals Enters into Licensing and Purchase …
Oct 26, 2009 Potentia Pharmaceuticals announced that it has entered into licensing and purchase option agreements with Alcon Research, Ltd., a wholly-owned subsidiary of Alcon, …See details»
Potentia Pharmaceuticals, Inc. Licenses Complement Inhibitor
Aug 8, 2006 Potentia disclaims any intent or obligation to update this press release or forward-looking statements contained therein. Our logo, trademarks, and service marks are the …See details»
Potentia Pharmaceuticals' Drug Candidate For Age-Related …
Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), presented Phase I data last week …See details»
Potentia Pharmaceuticals Announces Positive Safety Data and …
Sep 30, 2008 Potentia Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»